Venlafaxine and blood creatine phosphokinase increased Patient Reports February 12, 2012

Venlafaxine Side Effects Report #5298724-X
Venlafaxine side effect was reported by a Pharmacist from GERMANY on Apr 12, 2007. Female patient, weighting 121.3 lb, was diagnosed with panic disorder , agoraphobia and was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased. Venlafaxine dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, ATACAND. Patient was hospitalized. Patient recovered.

Venlafaxine Side Effects Report #4985881-5
Venlafaxine side effect was reported by a Health Professional from GERMANY on Apr 17, 2006. Female patient, 46 years of age, was diagnosed with overdose and was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood ph decreased, haematoma, hypothermia , intentional overdose, somnolence, suicide attempt. Venlafaxine dosage: unknown. During the same period patient was treated with BUSPIRONE, TRUXAL. Patient was hospitalized. Patient recovered.

Venlafaxine Side Effects Report #5787389-6
Venlafaxine side effect was reported by a Pharmacist from UNITED STATES on June 23, 2008. Male patient, 61 years of age, was diagnosed with depression , hyperlipidaemia and was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, depression , gait disturbance, myalgia, presyncope. Venlafaxine dosage: 375 MG BID PO. During the same period patient was treated with SIMVASTATIN. Patient recovered.

Venlafaxine Side Effects Report #5162138-3
Venlafaxine side effect was reported by a Consumer or non-health professional from GERMANY on Nov 15, 2006. Male patient, 41 years of age, was diagnosed with depression  and was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, musculoskeletal discomfort. Venlafaxine dosage: 225 MG PER DAY ORAL. During the same period patient was treated with MIRTAZAPINE. Patient recovered.


Venlafaxine Side Effects Report #5825257-1
Venlafaxine side effect was reported by a Physician from GERMANY on July 24, 2008. Male patient, weighting 183.0 lb, was diagnosed with depression  and was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood creatine phosphokinase increased, gamma-glutamyltransferase increased, muscle atrophy, peripheral paralysis. Venlafaxine dosage: unknown. Patient recovered.

Venlafaxine Side Effects Report #5158557-1
Venlafaxine side effect was reported by a Consumer or non-health professional from GERMANY on Nov 06, 2006. Female patient, 68 years of age, was diagnosed with apathy, asthenia, pain  and was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: apathy, blood alkaline phosphatase increased, blood cholesterol increased, blood creatine phosphokinase increased, blood glucose decreased, blood potassium increased, blood thyroid stimulating hormone increased, blood urea increased, coma. Venlafaxine dosage: 75 MG PER DAY. During the same period patient was treated with VENLAFAXINE EXTENDED, VENLAFAXINE EXTENDED, BUPRENORPHINE. Patient was hospitalized. Patient recovered.

Venlafaxine Side Effects Report #5096264-4
Venlafaxine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 17, 2006. Female patient, 71 years of age, was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: aspiration, atrioventricular block first degree, blood creatine phosphokinase increased, bradycardia, coma, suicide attempt, vomiting. Venlafaxine dosage: 100 CAPSULES (OVERDOSE MAOUNT 7500MG, ORAL. During the same period patient was treated with MELPERONE, MEMANTINE, REMERON. Patient was hospitalized. Patient recovered.

Venlafaxine Side Effects Report #5912043-7
Venlafaxine side effect was reported by a Health Professional from UNITED KINGDOM on Sept 23, 2008. Female patient, 49 years of age, was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: agitation, blood creatine phosphokinase increased, confusional state, glasgow coma scale abnormal, hyperhidrosis, hypoglycaemia, intentional overdose, metabolic acidosis, mydriasis. Venlafaxine dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Venlafaxine Side Effects Report #5196094-9
Venlafaxine side effect was reported by a Consumer or non-health professional from GERMANY on Dec 15, 2006. Female patient, 48 years of age, was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, bowel sounds abnormal, fatigue, intentional overdose, suicide attempt. Venlafaxine dosage: 40 CAPSULES (OVERDOSE AMOUNT 3000 MG), ORAL. Patient was hospitalized. Patient recovered.


Venlafaxine Side Effects Report #5810321-3
Venlafaxine side effect was reported by a Physician from GERMANY on July 07, 2008. Male patient, 45 years of age, was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood creatine phosphokinase increased, muscle atrophy, peripheral paralysis. Venlafaxine dosage: unknown. Patient recovered.

Venlafaxine Side Effects Report #4985765-2
Venlafaxine side effect was reported by a Physician from GERMANY on Apr 11, 2006. Female patient, 23 years of age, was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb abnormal, circulatory collapse, intentional overdose, mydriasis, myoclonus, serotonin syndrome, sopor. Venlafaxine dosage: 60 CAPSULES (OVERDOSE AMOUNT 4500 MG). Patient was hospitalized. Patient recovered.

Venlafaxine Side Effects Report #5033252-8
Venlafaxine side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient, 17 years of age, was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: aggression, blood creatine phosphokinase increased, mydriasis, suicide attempt, tachycardia. Venlafaxine dosage: 20 CAPSULES (OVERDOSE AMOUNT 3000 MG) ORAL. During the same period patient was treated with CYMBALTA, TRIMIPRAMINE. Patient was hospitalized. Patient recovered.

Venlafaxine Side Effects Report #5325490-1
Venlafaxine side effect was reported by a Health Professional from GERMANY on May 11, 2007. Female patient, weighting 143.3 lb, was treated with Venlafaxine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, bowel sounds abnormal, confusional state, disturbance in attention, electrocardiogram abnormal, hepatic enzyme increased, intentional overdose, polyuria, renal failure. Venlafaxine dosage: 120 CAPSULES (OVERDOSE AMOUNT 12750 MG). During the same period patient was treated with ZIPRASIDONE, IBUPROFEN, AMISULPRIDE, PROMETHAZINE. Patient was hospitalized. Patient recovered.